Navigation Links
Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Da Vinci Surgery Lawsuit Filings
Date:10/21/2013

heir legal counsel with additional time to evaluate the claims, and to explore whether the claims have merit and whether they can be resolved without litigation.”**

In June, NBC News reported that the agency had received more than 200 reports of da Vinci patients who suffered burns, cuts and infections since 2007, including 89 that involved patient death. The U.S. Food & Drug Administration (FDA) has also launched a survey of doctors who use the da Vinci, amid concerns about an increase in the number of robotic surgery complication reports involving the device.***

Robotic surgery patients who suffered serious injuries allegedly due to the da Vinci Surgical System may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury-related damages. Learn More about da Vinci surgical lawsuits at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*bloomberg.com/news/2013-10-17/intuitive-s-profit-declines-on-lower-da-vinci-robot-sales.html, Bloomberg.com, October 17, 2013
**sec.gov/Archives/edgar/data/1035267/000103526713000040/isrg-2013930x10q.htm, Intuitive Surgical SEC Filing, October 18, 2013
***rockcenter.nbcnews.com/_news/2013/06/14/18958967-robotic-surgery-is-high-tech-tour-de-force-but-is-it-safe, NBC News June 10, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Increase In Da Vinci Robot Lawsuit Filings by Alleged Victims of Da Vinci Surgery Complications Draws Comment from Wright & Schulte LLC
2. Two Surgeons Working with Intuitive Surgical to Promote the da Vinci Surgical Robot ‘Downplayed Risks,’ Reports the Orange County Register; Parker Waichman LLP Responds
3. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Report Detailing Researchers’ Ties to Intuitive Surgical, Inc.
4. Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP
5. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
6. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
7. Da Vinci Robotic Surgery Lawsuit Update: Wright & Schulte LLC Disturbed by Research Indicating Da Vinci Surgery Complications May Be Underreported
8. Da Vinci Surgery Lawsuit News: Bernstein Liebhard LLP Comments on New Research that Suggests Robotic Surgery Complications Underreported
9. Robotic Surgery Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Filing of Removal Notice in Pennsylvania Da Vinci Robot Lawsuit
10. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by Allegations in Latest Da Vinci Surgery Robot Lawsuit
11. Da Vinci Robot Lawsuit News: Da Vinci Robot Lawsuits Mount, as Alonso Krangle LLP Continues its Investigation of Alleged Da Vinci Complications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Pitt Researchers to ... University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative ... Africa. , A cooperative agreement awarded by the U.S. Agency for International ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent ... for drugs, biologics and consumer health products, today welcomed the announcement by OPKO ... New Drug Application for a new treatment for chronic kidney disease (CKD) and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched the ... as well as announced the date of its next major release. , Version ... management tasks as well as enhancements to the customer experience. Users now ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato ... new program “Designing Secure Healthcare Systems” This three-day, highly interactive and immersive ... healthcare organizations with access to the tactics, techniques and practices required to design ...
(Date:8/3/2015)... Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... Back Pain: Injection of Stem Cells Found to Release Natural Painkiller That Can Last ... pain in patients. According to the report, the new study showed that harvesting stem ...
Breaking Medicine News(10 mins):Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Novatus Unveils Milestone Software Release 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... fruit fly,s immune system can tell time, researchers at ... how hard it punches back against infections depends on ... could have implications for human health, too. , Working ... cycle and with syringes small enough to inject measured ...
... LLC will be featured in an upcoming episode. , ... Deerfield Beach, ... are pleased to announce that Gradient Medical, LLC will be featured in ... Tomorrow,s Health Solutions Today., , ,Pain is a national public healthcare crisis. ...
... of a breast cancer prevention study using exemestane (Aromasin) ... ongoing phase II study details reported today, by Jennifer ... Comprehensive Cancer Center at the San Antonio Breast Cancer ... who are at an increased risk of developing breast ...
... Expression of the microtubule-binding protein Tau is not a ... paclitaxel chemotherapy, according to research led by The University ... today, Dec. 13, at the CRTC-AACR San Antonio Breast ... predict survival, yet in an unexpected way. ...
... areas that show up light on a mammogram - ... "why" remains to be answered. Now, by examining dense ... volunteers, researchers from Mayo Clinic have found several potential ... poster form at the Cancer Therapy & Research Center-American ...
... the finish line in second place at the 2008 Ford Ironman ... for 34 year-old Jason Fowler, who was one of five wheelchair ... the Pacific Ocean, using only his arms, a 112-mile bike ride ... that Jason completed in a racing wheelchair in 90 degree heat. ...
Cached Medicine News:Health News:Snoring or soaring? Strength of fruit-fly immune system varies 2Health News:Snoring or soaring? Strength of fruit-fly immune system varies 3Health News:"The Economic Report" Show to Feature Gradient Medical, LLC 2Health News:Tau protein expression predicts breast cancer survival -- though not as expected 2Health News:Tau protein expression predicts breast cancer survival -- though not as expected 3Health News:Mayo researchers find potential links between breast density and breast cancer risk 2Health News:Mayo researchers find potential links between breast density and breast cancer risk 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 4Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 5
(Date:8/2/2015)... Calif. , Aug. 3, 2015  Isis ... today announced a strategic collaboration to discover and ... diseases. The new collaboration builds on a broad ... AstraZeneca,s strategic approach in these therapeutic areas using ... to extend use of its antisense technology to ...
(Date:8/2/2015)... , Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. ... pivotal TELESTAR Phase 3 clinical trial met its ... etiprate in treating cancer patients with carcinoid syndrome ... standard of care. Telotristat etiprate was discovered using ... and is the company,s first discovery to complete ...
(Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 /PRNewswire/ ... needs of customers who are increasingly mobile, increasingly connected, ... support a growing variety of customer interaction channels and ... of technology, including social media. According ... of the over the counter (OTC) segment in a ...
Breaking Medicine Technology:AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
... From simple techniques such as submarine electrophoresis ... Step IEF, the Series 90 Programmable Power ... Series 90 Programmable Power Supplies are available ... or 6000V., All models operate in constant ...
... - 200: 200V, .01-2A. 300: 300V, 4-400mA. ... Select constant voltage or constant current ... gels. - Compact, lightweight and stackable. - ... - Ideal for DNA, RNA and protein ...
... The MAX POWER Programmable Power Supply ... which can handle virtually any application ... current blotting. It is unique in ... The MAX POWER Programmable Power Supply ...
... The e-power series power ... any horizontal gel electrophoresis system. ... constructed to the most rigorous ... recognition as the most compact ...
Medicine Products: